Low
₹1,112.90
High
₹1,147.50
| Previous Close | ₹1,125.30 |
|---|---|
| Day's Range | ₹1,112.90 - ₹1,147.50 |
| Open | ₹1,139.50 |
| 52 Week Range | ₹538.25 - ₹1,184.00 |
| Volume | 5,58,832 |
| Market Cap | ₹0.01 |
| Previous Close | ₹1,123.25 |
|---|---|
| Day's Range | ₹1,112.15 - ₹1,148.70 |
| Open | ₹1,148.70 |
| 52 Week Range | ₹538.15 - ₹1,183.15 |
| Volume | 46,815 |
| Market Cap | ₹0.01 |
| Trade Value ( ₹ in Lacs) | 6,298.31 |
|---|---|
| Market Cap (₹ in Mn) | 0.01 |
| Dividend Yield(%) | 0.00 |
| Price/Earning (TTM) | 59.74 |
| TTM EPS (₹) | 18.80 |
| P/E Ratio | 33.91 |
| Book Value(₹) | 5.93 |
| PAT Margin (%) | 14.11 |
| Face Value (₹) | 10.00 |
| ROCE(%) | 13.30 |
| Trade Value ( ₹ in Lacs) | 527.98 |
|---|---|
| Market Cap (₹ in Mn) | 0.01 |
| Dividend Yield(%) | 0.00 |
| Price/Earning (TTM) | 59.74 |
| TTM EPS (₹) | 18.80 |
| P/E Ratio | 33.91 |
| Book Value(₹) | 5.93 |
| PAT Margin (%) | 14.11 |
| Face Value (₹) | 10.00 |
| ROCE(%) | 13.30 |
| Particulars | QTR FY (₹ in Millions) | Annual FY (₹ in Millions) |
|---|---|---|
| Net sales | 2592.47 | 4564.84 |
| Expenses | N/A | N/A |
| PBT | 586.88 | 1194.31 |
| Operating profit | 0.0 | 0.0 |
| Net profit | 420.4 | 876.92 |
| Founded | 2008 |
|---|---|
| Managing Director | Kapil Kumar |
| NSE Symbol | YATHARTH |
| Stocks Name | Market Cap (Cr)(₹) | Market Price (₹) | 52 Week Low-High (₹) |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 4,48,195.77 | 1,868.00 | 1,548.00 - 1,548.00 |
| Divi's Laboratories Ltd. | 2,50,389.96 | 9,432.00 | 5,636.50 - 5,636.50 |
| Torrent Pharmaceuticals Ltd. | 1,88,966.75 | 4,968.00 | 3,480.60 - 3,480.60 |
| Apollo Hospitals Enterprise Ltd. | 1,28,543.48 | 8,940.00 | 6,696.50 - 6,696.50 |
| Lenskart Solutions Ltd. | 1,18,933.76 | 685.00 | 0.00 - 0.00 |
| Zydus Lifesciences Ltd. | 1,15,860.07 | 1,161.50 | 835.50 - 835.50 |
| Cipla Ltd. | 1,11,888.39 | 1,385.00 | 1,165.70 - 1,165.70 |
| Laurus Labs Ltd. | 1,09,035.01 | 2,018.00 | 823.10 - 823.10 |
| Max Healthcare Institute Ltd. | 1,03,608.88 | 1,064.50 | 903.00 - 903.00 |
| Mankind Pharma Ltd. | 1,00,363.76 | 2,429.85 | 1,909.70 - 1,909.70 |
No Records Found
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Yatharth Hospital & Trauma Care Services has informed that it enclosed the Investor’s Presentation on financial results of the Company for the Q1FY27. The above presentation will also be made available on website of the Company at https://www.yatharthhospitals.com/investors/corporate-announcements.
The above information is a part of company’s filings submitted to BSE.
No Records Found
The current share price of Yatharth Hospital & Trauma Care Services Ltd. is ₹1,125.30 as of 2026-09-21.
The market capitalisation of Yatharth Hospital & Trauma Care Services Ltd. is ₹10,823.00 as of 2026-09-21.
The 1-year return of Yatharth Hospital & Trauma Care Services Ltd. is 348.85% as of 2026-09-21.
The P/E ratio of Yatharth Hospital & Trauma Care Services Ltd. is 33.91 as of 2026-09-22.
The 52-week high and low of Yatharth Hospital & Trauma Care Services Ltd. are ₹1,184.00 and ₹538.25, respectively, as of 2026-09-21.
Yatharth Hospital & Trauma Care Services Ltd. collaborates with pharmaceutical companies and other healthcare entities through clinical practices, procurement of medical equipment, and integration of healthcare technologies. Its hospitals may also serve as clinical settings for treatment protocols and the use of advanced medical devices, while partnering with suppliers to maintain modern healthcare infrastructure.
Yatharth Hospital & Trauma Care Services Ltd. operates multi-specialty hospitals, primarily located in the National Capital Region (NCR). Its facilities provide a range of healthcare services, including trauma care, cardiology, orthopedics, and critical care, supported by intensive care units and related medical infrastructure.
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.